SCHEMBL20161153

SCHEMBL20161153

COC(=O)c1cccc2nc3n(c(=O)c12)CCN(C(=O)OCc1ccccc1)C3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
PARP1 P09874 2/20 0.40
TNKS O95271 1/20 0.40
TNKS2 Q9H2K2 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
TMEM97 Q5BJF2 3/20 0.39
SIGMAR1 Q99720 3/20 0.39
GRIN2B Q13224 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HTT P42858 2/20 0.39
TSHR P16473 1/20 0.39
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
TP53 P04637 1/20 0.38
FAAH O00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20152907 0.91 PARP1 (0.42) ALDH1A1NPC1RAB9ASMN1; SMN2PARP1
SCHEMBL20036990 0.83 NR1H2 (0.49) ALDH1A1PARP1TNKS2PARP2HTT
SCHEMBL1976458 0.73 MEN1 (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2TMEM97
SCHEMBL20036994 0.72 KDM4E (0.43) ALDH1A1PARP1MEN1KMT2ATSHR
SCHEMBL1964904 0.72 MEN1 (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2TMEM97
SCHEMBL839899 0.71 ALDH1A1 (0.50) ALDH1A1NPC1RAB9ASMN1; SMN2TMEM97
SCHEMBL10095052 0.70 PDK2 (0.54) NPC1RAB9ASMN1; SMN2TMEM97SIGMAR1
SCHEMBL21809822 0.70 HTT (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2TMEM97
SCHEMBL1967826 0.69 MEN1 (0.48) NPC1RAB9ASMN1; SMN2TMEM97SIGMAR1
SCHEMBL839900 0.69 RAB9A (0.60) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134722-A1 AZA-PHENALENE-3-KETONE DERIVATIVE, PREPARATION METHOD THEREOF, AND ITS APPLICATION AS PARP INHIBITOR SUZHOU KANGRUN PHARMACEUTICALS INC. (CN) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134722-A1 AZA-PHENALENE-3-KETONE DERIVATIVE, PREPARATION METHOD THEREOF, AND ITS APPLICATION AS PARP INHIBITOR PARP1, PARP11, PARP3 ALDH1A1 812/4885NPC1 3714/4885RAB9A 3973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.